Delcath Systems, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
DCTH Nasdaq 2836 www.delcath.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Delcath Systems, Inc.

Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts - May 26th, 2026 2:01 pm
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 15th, 2026 2:01 pm
Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference - May 12th, 2026 6:00 am
Delcath (DCTH) Q1 2026 Earnings Transcript - May 8th, 2026 10:25 am
Delcath Systems Q1 Earnings Call Highlights - May 7th, 2026 11:42 am
Delcath Systems, Inc. (DCTH) Reports Q1 Loss, Misses Revenue Estimates - May 7th, 2026 9:15 am
Delcath Systems Reports First Quarter 2026 Results and Business Highlights - May 7th, 2026 6:00 am
Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026 - May 7th, 2026 5:00 am
How The Delcath Systems (DCTH) Story Is Shifting With Hepzato Milestones And 2026 Guidance - May 1st, 2026 3:20 am
Delcath Systems to Host First Quarter 2026 Earnings Call - Apr 23rd, 2026 6:30 am
Implied Volatility Surging for Delcath Systems Stock Options - Apr 7th, 2026 8:06 am
Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma - Apr 6th, 2026 6:30 am
Delcath Systems to Participate at the Society of Interventional Radiology 2026 Meeting - Apr 1st, 2026 6:30 am
Delcath Systems publishes results from CHOPIN trial in The Lancet Oncology - Mar 4th, 2026 6:43 am
Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology - Mar 3rd, 2026 6:00 am
Delcath Systems Inc (DCTH) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... - Feb 26th, 2026 2:09 pm
Delcath Systems Q4 Earnings Call Highlights - Feb 26th, 2026 1:48 pm
Delcath (DCTH) Q4 2025 Earnings Call Transcript - Feb 26th, 2026 8:33 am
Delcath Systems, Inc. Q4 2025 Earnings Call Summary - Feb 26th, 2026 6:30 am
Delcath Systems Reports Fourth Quarter and Full Year 2025 Results - Feb 26th, 2026 6:00 am